CBLA
Cannabicyclolic acid

How it occurs

Associated with transformation of CBCA under light and environmental exposure.

Relationship to other cannabinoids

Part of the wider cannabinoid family; its exact pathway and relevance depend on the compound and source material.

What is established

Its identity and chemical relationship to CBCA/CBL are reported.

Commonly reported effects

Reliable consumer-effect patterns are not established. Product marketing and isolated anecdotes should not be treated as clinical evidence.

Anecdotal or marketing-led unless stated otherwise

What remains uncertain

Human pharmacology and consumer relevance remain largely unknown.

Evidence quality

Analytical chemistry; minimal biological evidence.

Safety and potential interactions

Human safety evidence is not established.

Vaporization relevance

Heating can change cannabinoid form and delivery, but laboratory boiling points do not define a universal device setting. Heater design, sensor position, airflow, material, load, and draw behavior all affect exposure. This entry makes no compound-specific temperature recommendation.

Legal and regulatory context

Governed through the source product and applicable jurisdiction.

Dated source foundation

Direct authoritative sources reviewed 2026-08-20. These sources support the safety and regulatory boundaries of this draft; a scientific editor must still verify compound-specific claims against current peer-reviewed literature.

• FDA — Cannabis and cannabis-derived products: questions and answers ↗
• FDA — What to know about cannabis and CBD products ↗
• NIDA — Cannabis (Marijuana) ↗
• CDC — Cannabis frequently asked questions ↗

Related entries

THC · CBD · CBG

← All encyclopedia entries